Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall association with chronic inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayek, Salim S., Ko, Yi-An, Awad, Mosaab, Ahmed, Hina, Gray, Brandon, Hosny, Kareem Mohammed, Aida, Hiroshi, Tracy, Melissa J., Wei, Changli, Sever, Sanja, Reiser, Jochen, Quyyumi, Arshed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678674/
https://www.ncbi.nlm.nih.gov/pubmed/29142970
http://dx.doi.org/10.1016/j.ekir.2017.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678674/
https://www.ncbi.nlm.nih.gov/pubmed/29142970
http://dx.doi.org/10.1016/j.ekir.2017.02.001

Ejemplares similares